361 related articles for article (PubMed ID: 22815789)
1. Myeloid suppressor cell depletion augments antitumor activity in lung cancer.
Srivastava MK; Zhu L; Harris-White M; Kar UK; Huang M; Johnson MF; Lee JM; Elashoff D; Strieter R; Dubinett S; Sharma S
PLoS One; 2012; 7(7):e40677. PubMed ID: 22815789
[TBL] [Abstract][Full Text] [Related]
2. GITR agonist enhances vaccination responses in lung cancer.
Zhu LX; Davoodi M; Srivastava MK; Kachroo P; Lee JM; St John M; Harris-White M; Huang M; Strieter RM; Dubinett S; Sharma S
Oncoimmunology; 2015 Apr; 4(4):e992237. PubMed ID: 26137407
[TBL] [Abstract][Full Text] [Related]
3. Bortezomib treatment and regulatory T-cell depletion enhance the antitumor effects of adoptively infused NK cells.
Lundqvist A; Yokoyama H; Smith A; Berg M; Childs R
Blood; 2009 Jun; 113(24):6120-7. PubMed ID: 19202127
[TBL] [Abstract][Full Text] [Related]
4. Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment.
Cekic C; Day YJ; Sag D; Linden J
Cancer Res; 2014 Dec; 74(24):7250-9. PubMed ID: 25377469
[TBL] [Abstract][Full Text] [Related]
5. Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells.
Husain Z; Huang Y; Seth P; Sukhatme VP
J Immunol; 2013 Aug; 191(3):1486-95. PubMed ID: 23817426
[TBL] [Abstract][Full Text] [Related]
6. MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.
Finke J; Ko J; Rini B; Rayman P; Ireland J; Cohen P
Int Immunopharmacol; 2011 Jul; 11(7):856-61. PubMed ID: 21315783
[TBL] [Abstract][Full Text] [Related]
7. CpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice.
Zoglmeier C; Bauer H; Noerenberg D; Wedekind G; Bittner P; Sandholzer N; Rapp M; Anz D; Endres S; Bourquin C
Clin Cancer Res; 2011 Apr; 17(7):1765-75. PubMed ID: 21233400
[TBL] [Abstract][Full Text] [Related]
8. Role of CXCR3 ligands in IL-7/IL-7R alpha-Fc-mediated antitumor activity in lung cancer.
Andersson A; Srivastava MK; Harris-White M; Huang M; Zhu L; Elashoff D; Strieter RM; Dubinett SM; Sharma S
Clin Cancer Res; 2011 Jun; 17(11):3660-72. PubMed ID: 21636553
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth.
Porembka MR; Mitchem JB; Belt BA; Hsieh CS; Lee HM; Herndon J; Gillanders WE; Linehan DC; Goedegebuure P
Cancer Immunol Immunother; 2012 Sep; 61(9):1373-85. PubMed ID: 22215137
[TBL] [Abstract][Full Text] [Related]
10. Cyclophosphamide-induced myeloid-derived suppressor cell population is immunosuppressive but not identical to myeloid-derived suppressor cells induced by growing TC-1 tumors.
Mikyšková R; Indrová M; Polláková V; Bieblová J; Símová J; Reiniš M
J Immunother; 2012 Jun; 35(5):374-84. PubMed ID: 22576342
[TBL] [Abstract][Full Text] [Related]
11. Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma.
Kapanadze T; Gamrekelashvili J; Ma C; Chan C; Zhao F; Hewitt S; Zender L; Kapoor V; Felsher DW; Manns MP; Korangy F; Greten TF
J Hepatol; 2013 Nov; 59(5):1007-13. PubMed ID: 23796475
[TBL] [Abstract][Full Text] [Related]
12. Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer.
Albeituni SH; Ding C; Liu M; Hu X; Luo F; Kloecker G; Bousamra M; Zhang HG; Yan J
J Immunol; 2016 Mar; 196(5):2167-80. PubMed ID: 26810222
[TBL] [Abstract][Full Text] [Related]
13. T cells conditioned with MDSC show an increased anti-tumor activity after adoptive T cell based immunotherapy.
Raber PL; Sierra RA; Thevenot PT; Shuzhong Z; Wyczechowska DD; Kumai T; Celis E; Rodriguez PC
Oncotarget; 2016 Apr; 7(14):17565-78. PubMed ID: 27007050
[TBL] [Abstract][Full Text] [Related]
14. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.
Li H; Han Y; Guo Q; Zhang M; Cao X
J Immunol; 2009 Jan; 182(1):240-9. PubMed ID: 19109155
[TBL] [Abstract][Full Text] [Related]
15. Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model.
Meyer C; Sevko A; Ramacher M; Bazhin AV; Falk CS; Osen W; Borrello I; Kato M; Schadendorf D; Baniyash M; Umansky V
Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17111-6. PubMed ID: 21969559
[TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin facilitates tumor-infiltration of T cells and natural-killer cells for enhanced tumor immunotherapy in lung cancer model.
Xin M; Lin D; Yan N; Li H; Li J; Huang Z
Anticancer Drugs; 2022 Feb; 33(2):117-123. PubMed ID: 34561996
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer.
Alizadeh D; Trad M; Hanke NT; Larmonier CB; Janikashvili N; Bonnotte B; Katsanis E; Larmonier N
Cancer Res; 2014 Jan; 74(1):104-18. PubMed ID: 24197130
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effect of malaria parasite infection in a murine Lewis lung cancer model through induction of innate and adaptive immunity.
Chen L; He Z; Qin L; Li Q; Shi X; Zhao S; Chen L; Zhong N; Chen X
PLoS One; 2011; 6(9):e24407. PubMed ID: 21931708
[TBL] [Abstract][Full Text] [Related]
19. Silymarin suppressed lung cancer growth in mice via inhibiting myeloid-derived suppressor cells.
Wu T; Liu W; Guo W; Zhu X
Biomed Pharmacother; 2016 Jul; 81():460-467. PubMed ID: 27261626
[TBL] [Abstract][Full Text] [Related]
20. IL-7 promotes CXCR3 ligand-dependent T cell antitumor reactivity in lung cancer.
Andersson A; Yang SC; Huang M; Zhu L; Kar UK; Batra RK; Elashoff D; Strieter RM; Dubinett SM; Sharma S
J Immunol; 2009 Jun; 182(11):6951-8. PubMed ID: 19454692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
